EVHEvolent Health, Inc.
$3.95-51% 1Y
$3.95
$2.1752 weeks$8.18
Is the price fair?
What EVH's price assumes
Evolent Health, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.14× revenue.
0.14
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.65
Price / book · as of 2026-Q1
- EV / sales
- 0.58
EV / sales
Details›
- Price / bookas of 2026-Q1
- 0.65
- EV / EBIToperating margin −20%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q1
- 0.58
- Market capitalisation
- $444M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #19 of 20 by RyuScore